AUB
PSTV

Atlantic Union Bankshares’s Plus Therapeutics PSTV Stock Holding History

Atlantic Union Bankshares’s Portfolio PSTV Stock Details PSTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$174 – 1684
2025
Q2 		$174 Buy
+20
New +$262 ﹤0.01% 1184

Other funds holding PSTV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Atlantic Union Bankshares's PSTV Position: Q3 2025 in Review

Atlantic Union Bankshares sold out of Plus Therapeutics (PSTV) in Q3 2025, closing a stake of 20 shares — an estimated $174 sold.

Atlantic Union Bankshares first reported a position in PSTV in Q2 2025 and held it in 1 quarter. The position peaked at $174 in Q2 2025. 20 funds tracked by Wall St. Rank hold PSTV as of Q3 2025.

  • Atlantic Union Bankshares reported no remaining Plus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Atlantic Union Bankshares sold 20 Plus Therapeutics shares in Q3 2025, an estimated $174.
  • Atlantic Union Bankshares first reported a position in Plus Therapeutics in Q2 2025 and held it in 1 quarter.
  • Atlantic Union Bankshares's Plus Therapeutics position peaked at $174 in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Plus Therapeutics as of Q3 2025.

Based on Atlantic Union Bankshares's 13F filing for Q3 2025, filed 4 Nov 2025.